Platform Technologies in Drug Discovery and Validation
Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Science & Nature, Science, Chemistry, General Chemistry
| Author: | Robert A. Goodnow | ISBN: | 9780128130704 |
| Publisher: | Elsevier Science | Publication: | November 21, 2017 |
| Imprint: | Academic Press | Language: | English |
| Author: | Robert A. Goodnow |
| ISBN: | 9780128130704 |
| Publisher: | Elsevier Science |
| Publication: | November 21, 2017 |
| Imprint: | Academic Press |
| Language: | English |
Platform Technologies in Drug Discovery and Validation, Volume 50, the latest release in the Annual Reports in Medicinal Chemistry series, provides timely and critical reviews of important topics in medicinal chemistry, with an emphasis on emerging topics in the biological sciences. Topics covered in this new volume include DELT, Oligos: ASO, siRNA, CRISPR, Micro-fluidic chemistry, High throughput screening, Kinase-centric computational drug development, Virtual Screening, Phenotypic screening, PROTACS, Chemical Biology, Fragment-based lead generation, Antibody-Drug Conjugates, Antibody-recruiting small molecules, Deuteration, and Peptides.
- Unique for its treatment of platform technologies for medicinal chemistry and target validation
- Provides a single, rich volume that summaries a broad spectrum of expertise relevant to the field
- Presents state-of-the-art summaries of platform technologies
Platform Technologies in Drug Discovery and Validation, Volume 50, the latest release in the Annual Reports in Medicinal Chemistry series, provides timely and critical reviews of important topics in medicinal chemistry, with an emphasis on emerging topics in the biological sciences. Topics covered in this new volume include DELT, Oligos: ASO, siRNA, CRISPR, Micro-fluidic chemistry, High throughput screening, Kinase-centric computational drug development, Virtual Screening, Phenotypic screening, PROTACS, Chemical Biology, Fragment-based lead generation, Antibody-Drug Conjugates, Antibody-recruiting small molecules, Deuteration, and Peptides.
- Unique for its treatment of platform technologies for medicinal chemistry and target validation
- Provides a single, rich volume that summaries a broad spectrum of expertise relevant to the field
- Presents state-of-the-art summaries of platform technologies
